Tactiva Therapeutics

Tactiva Therapeutics is combating cancer by developing "next-generation" Adoptive Cell Therapy (ACT) strategies capable of delivering a lethal blow to cancer cells. Our approach provides tumors with a powerful and sustained immune attack by infusing large quantities of the patient’s own T cells, which can recognize, attack, and destroy cancer cells.